| scholarly article | Q13442814 |
| P50 | author | Mitchell J Weiss | Q57032299 |
| P2093 | author name string | Jingping Ge | |
| Deborah L French | |||
| Paul Gadue | |||
| Shefali Parikh | |||
| Monica Bessler | |||
| Philip J Mason | |||
| Lisa M Sullivan | |||
| Jason A Mills | |||
| Loïc Garçon | |||
| Gregory M Podsakoff | |||
| Shwetha H Manjunath | |||
| Marisa Apicella | |||
| P2860 | cites work | Human RPS19, the gene mutated in Diamond-Blackfan anemia, encodes a ribosomal protein required for the maturation of 40S ribosomal subunits | Q24304155 |
| Missense mutations associated with Diamond-Blackfan anemia affect the assembly of ribosomal protein S19 into the ribosome | Q24306589 | ||
| Impaired ribosome biogenesis in Diamond-Blackfan anemia | Q24307762 | ||
| Nuclear export and cytoplasmic processing of precursors to the 40S ribosomal subunits in mammalian cells. | Q24309380 | ||
| The role of human ribosomal proteins in the maturation of rRNA and ribosome production | Q24322949 | ||
| Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients | Q24643416 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| In vivo genome editing restores haemostasis in a mouse model of haemophilia | Q28241725 | ||
| The ribosomal basis of Diamond-Blackfan Anemia: mutation and database update | Q28296164 | ||
| Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases | Q29622846 | ||
| Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. | Q30489278 | ||
| Clinical and laboratory evidence for a trilineage haematopoietic defect in patients with refractory Diamond-Blackfan anaemia | Q33331340 | ||
| Hematopoietic and endothelial differentiation of human induced pluripotent stem cells | Q34099344 | ||
| Characterization of a novel association between two trypanosome-specific proteins and 5S rRNA. | Q34130933 | ||
| Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemia | Q34223265 | ||
| A transgenic mouse model demonstrates a dominant negative effect of a point mutation in the RPS19 gene associated with Diamond-Blackfan anemia | Q34282262 | ||
| Investigation of a putative role for FLVCR, a cytoplasmic heme exporter, in Diamond-Blackfan anemia. | Q34431302 | ||
| Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells | Q34707415 | ||
| Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting | Q35030912 | ||
| Fetal Diamond-Blackfan anemia associated with hydrops fetalis | Q35600116 | ||
| Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures | Q35849083 | ||
| Primary hematopoietic cells from DBA patients with mutations in RPL11 and RPS19 genes exhibit distinct erythroid phenotype in vitro. | Q36121754 | ||
| Expression of ribosomal protein genes cloned in a hybrid plasmid in Escherichia coli: gene dosage effects on synthesis of ribosomal proteins and ribosomal protein messenger ribonucleic acid | Q36337168 | ||
| Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells | Q36378400 | ||
| Targeted disruption of the ribosomal protein S19 gene is lethal prior to implantation | Q37424374 | ||
| p53: Guardian of reprogramming | Q37800333 | ||
| Diamond Blackfan anemia: ribosomal proteins going rogue. | Q37857418 | ||
| Diamond Blackfan anemia | Q37967332 | ||
| Suprainduction of p53 by disruption of 40S and 60S ribosome biogenesis leads to the activation of a novel G2/M checkpoint. | Q39347844 | ||
| Robust, persistent transgene expression in human embryonic stem cells is achieved with AAVS1-targeted integration | Q40048821 | ||
| Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures | Q40200355 | ||
| Pathogenesis of the erythroid failure in Diamond Blackfan anaemia | Q40436169 | ||
| Deficiency of ribosomal protein S19 in CD34+ cells generated by siRNA blocks erythroid development and mimics defects seen in Diamond-Blackfan anemia. | Q40475890 | ||
| Nonsense-mediated and nonstop decay of ribosomal protein S19 mRNA in Diamond-Blackfan anemia | Q40496380 | ||
| The accumulation of three yeast ribosomal proteins under conditions of excess mRNA is determined primarily by fast protein decay | Q40648444 | ||
| Proliferation deficiency of multipotent hematopoietic progenitors in ribosomal protein S19 (RPS19)-deficient diamond-Blackfan anemia improves following RPS19 gene transfer | Q40651706 | ||
| An intrinsic progenitor defect in Diamond-Blackfan anaemia | Q41807803 | ||
| Hematopoietic defects in rps29 mutant zebrafish depend upon p53 activation | Q42572950 | ||
| Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family | Q43692423 | ||
| RNA and protein evidence for haplo-insufficiency in Diamond-Blackfan anaemia patients with RPS19 mutations | Q45072261 | ||
| Gene therapy of Diamond Blackfan anemia CD34(+) cells leads to improved erythroid development and engraftment following transplantation. | Q45879795 | ||
| Study of the effects of proteasome inhibitors on ribosomal protein S19 (RPS19) mutants, identified in patients with Diamond-Blackfan anemia | Q46392375 | ||
| Deficiency of ribosomal protein S19 during early embryogenesis leads to reduction of erythrocytes in a zebrafish model of Diamond-Blackfan anemia | Q46463636 | ||
| Cells depleted for RPS19, a protein associated with Diamond Blackfan Anemia, show defects in 18S ribosomal RNA synthesis and small ribosomal subunit production. | Q50701618 | ||
| Translational efficiency in patients with Diamond-Blackfan anemia. | Q50716094 | ||
| Ataxia-telangiectasia mutated (ATM) deficiency decreases reprogramming efficiency and leads to genomic instability in iPS cells. | Q53262677 | ||
| Long-term bone marrow cultures in Diamond-Blackfan anemia reveal a defect of both granulomacrophage and erythroid progenitors | Q57013378 | ||
| Age‐related alterations in erythroid and granulopoietic progenitors in Diamond‐Blackfan anaemia | Q71654194 | ||
| Erythroid failure in Diamond-Blackfan anemia is characterized by apoptosis | Q72749884 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 912-921 | |
| P577 | publication date | 2013-06-06 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Ribosomal and hematopoietic defects in induced pluripotent stem cells derived from Diamond Blackfan anemia patients | |
| P478 | volume | 122 |
| Q33864534 | Altered translation of GATA1 in Diamond-Blackfan anemia |
| Q47073215 | Bone marrow failure and developmental delay caused by mutations in poly(A)-specific ribonuclease (PARN). |
| Q37633372 | Concise Review: Getting to the Core of Inherited Bone Marrow Failures. |
| Q48276800 | Confounding in ex vivo models of Diamond-Blackfan anemia |
| Q51530791 | Critical Diamond-Blackfan anemia due to ribosomal protein S19 missense mutation. |
| Q38590664 | Current status of pluripotent stem cells: moving the first therapies to the clinic. |
| Q35533599 | De novo generation of HSCs from somatic and pluripotent stem cell sources |
| Q64075943 | Diamond Blackfan Anemia: Genetics, Pathogenesis, Diagnosis and Treatment |
| Q40343635 | Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitors |
| Q35741406 | Dysregulation of the Transforming Growth Factor β Pathway in Induced Pluripotent Stem Cells Generated from Patients with Diamond Blackfan Anemia. |
| Q36290454 | Efficient Recombinase-Mediated Cassette Exchange in hPSCs to Study the Hepatocyte Lineage Reveals AAVS1 Locus-Mediated Transgene Inhibition |
| Q58563105 | Emerging Therapeutic Approaches for Diamond Blackfan Anemia |
| Q89603279 | Emerging patent landscape for non-viral vectors used for gene therapy |
| Q38592859 | From Genomics to Gene Therapy: Induced Pluripotent Stem Cells Meet Genome Editing |
| Q90744990 | Gene editing of PKLR gene in human hematopoietic progenitors through 5' and 3' UTR modified TALEN mRNA |
| Q90706174 | Guide snoRNAs: Drivers or Passengers in Human Disease? |
| Q40111487 | Immortalization of erythroid progenitors for in vitro large-scale red cell production |
| Q35620795 | Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients |
| Q27016090 | Induced pluripotent stem cells in hematology: current and future applications |
| Q37462880 | Induction of multipotential hematopoietic progenitors from human pluripotent stem cells via respecification of lineage-restricted precursors |
| Q48690318 | Li-Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53. |
| Q37501610 | LiPS-A3S, a human genomic site for robust expression of inserted transgenes |
| Q41696611 | Lymphoblastoid cell lines from Diamond Blackfan anaemia patients exhibit a full ribosomal stress phenotype that is rescued by gene therapy |
| Q34431422 | Marrow failure: a window into ribosome biology |
| Q39306963 | Modeling Cancer with Pluripotent Stem Cells |
| Q57490090 | Modeling Hematological Diseases and Cancer With Patient-Specific Induced Pluripotent Stem Cells |
| Q28083303 | Modeling Human Bone Marrow Failure Syndromes Using Pluripotent Stem Cells and Genome Engineering |
| Q92570903 | Modeling blood diseases with human induced pluripotent stem cells |
| Q38854631 | Molecular convergence in ex vivo models of Diamond-Blackfan anemia |
| Q38653083 | Osteosarcoma: Molecular Pathogenesis and iPSC Modeling |
| Q63359425 | Patient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia A |
| Q49575039 | Perspective on Diamond-Blackfan anemia: lessons from a rare congenital bone marrow failure syndrome |
| Q99248457 | Pluripotent stem cell model of Shwachman-Diamond syndrome reveals apoptotic predisposition of hemoangiogenic progenitors |
| Q42724306 | Proteolytic autodigestion: common tissue pathology in Shwachman-Diamond syndrome? |
| Q65002709 | Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders. |
| Q28078535 | Regulatory Roles of Rpl22 in Hematopoiesis: An Old Dog with New Tricks |
| Q34465473 | Ribosomal proteins: functions beyond the ribosome |
| Q26781845 | Ribosomopathies: how a common root can cause a tree of pathologies |
| Q39063423 | Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation |
| Q35951882 | Transcriptome analysis reveals a ribosome constituents disorder involved in the RPL5 downregulated zebrafish model of Diamond-Blackfan anemia |
| Q39873476 | Using induced human pluripotent stem cells to study Diamond-Blackfan anemia: an outlook on the clinical possibilities. |
| Q39015278 | Utilization of the AAVS1 safe harbor locus for hematopoietic specific transgene expression and gene knockdown in human ES cells |
| Q90632986 | Zebrafish Models of Diamond-Blackfan Anemia: A Tool for Understanding the Disease Pathogenesis and Drug Discovery |
| Q35099802 | p53-Independent cell cycle and erythroid differentiation defects in murine embryonic stem cells haploinsufficient for Diamond Blackfan anemia-proteins: RPS19 versus RPL5. |
Search more.